A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma

PURPOSE: Standard care for unresectable locally advanced esophageal squamous cell carcinoma (ESCC) is concurrent chemoradiotherapy, but survival remains limited. Neoadjuvant chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) has demonstrated promising activity, with a pathological complet...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Chemother Pharmacol
Auteurs principaux: Satake, Hironaga, Tahara, Makoto, Mochizuki, Satoshi, Kato, Ken, Hara, Hiroki, Yokota, Tomoya, Kiyota, Naomi, Kii, Takayuki, Chin, Keisho, Zenda, Sadamoto, Kojima, Takashi, Bando, Hideaki, Yamazaki, Tomoko, Iwasa, Satoru, Honma, Yoshitaka, Hamauchi, Satoru, Tsushima, Takahiro, Ohtsu, Atsushi
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4921115/
https://ncbi.nlm.nih.gov/pubmed/27193097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-3062-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires